With unrivaled expertise in immunology on both sides of the client/CRO relationship, and operating sites in North America (East and West Coast) and Europe, Nexelis is a leading provider of assay development and advanced laboratory testing services in the infectious diseases, metabolic diseases, and oncology fields.
Our versatile team of scientists, working with our advanced technology platforms, were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 100 new molecular entities, including blockbuster vaccines, anti-viral drugs, and immunotherapy, gene and cell therapy products.
quality commitmentlearn more
We are committed to world-class standards through robust scientific and data processes. Our processes are optimized to ensure we deliver results of utmost quality while maintaining sample and data integrity. Our well-established quality management system is supported by global accreditation and lab certifications.